TORONTO, Feb. 8, 2023 – LEO Pharma Inc. today announced the Health Canada approval of Adtralza® (tralokinumab) for adolescent…
TORONTO, Feb. 8, 2023 – LEO Pharma Inc. today announced the Health Canada approval of Adtralza® (tralokinumab) for adolescent…